Jones Financial Companies Lllp Lucid Diagnostics Inc. Transaction History
Jones Financial Companies Lllp
- $86.5 Billion
- Q2 2024
A detailed history of Jones Financial Companies Lllp transactions in Lucid Diagnostics Inc. stock. As of the latest transaction made, Jones Financial Companies Lllp holds 3,831 shares of LUCD stock, worth $3,141. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,831
Previous 3,831
-0.0%
Holding current value
$3,141
Previous $3,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding LUCD
# of Institutions
36Shares Held
2.07MCall Options Held
0Put Options Held
0-
Luminus Management LLC Houston, TX726KShares$595,1760.4% of portfolio
-
Vanguard Group Inc Valley Forge, PA561KShares$459,9500.0% of portfolio
-
Geode Capital Management, LLC Boston, MA204KShares$167,5710.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT126KShares$103,6160.01% of portfolio
-
Ayrton Capital LLC Westport, CT73.9KShares$60,6033.26% of portfolio
About Lucid Diagnostics Inc.
- Ticker LUCD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 38,568,500
- Market Cap $31.6M
- Description
- Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease, which is also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarc...